126 related articles for article (PubMed ID: 30194594)
1. Methods for Identifying Virus-Derived Serpins.
Rahman MM
Methods Mol Biol; 2018; 1826():73-86. PubMed ID: 30194594
[TBL] [Abstract][Full Text] [Related]
2. Deriving Immune-Modulating Peptides from Viral Serine Protease Inhibitors (Serpins).
Yaron JR; Zhang L; Burgin M; Schutz LN; Awo EA; Keinan S; McFadden G; Ambadapadi S; Guo Q; Chen H; Lucas AR
Methods Mol Biol; 2021; 2225():107-123. PubMed ID: 33108660
[TBL] [Abstract][Full Text] [Related]
3. Characterization and functional analysis of Serp3: a novel myxoma virus-encoded serpin involved in virulence.
Guerin JL; Gelfi J; Camus C; Delverdier M; Whisstock JC; Amardeihl MF; Py R; Bertagnoli S; Messud-Petit F
J Gen Virol; 2001 Jun; 82(Pt 6):1407-1417. PubMed ID: 11369885
[TBL] [Abstract][Full Text] [Related]
4. Post-translational modification of the myxoma-virus anti-inflammatory serpin SERP-1 by a virally encoded sialyltransferase.
Nash P; Barry M; Seet BT; Veugelers K; Hota S; Heger J; Hodgkinson C; Graham K; Jackson RJ; McFadden G
Biochem J; 2000 Apr; 347(Pt 2):375-82. PubMed ID: 10749666
[TBL] [Abstract][Full Text] [Related]
5. Suppression of collagen-induced arthritis with a serine proteinase inhibitor (serpin) derived from myxoma virus.
Brahn E; Lee S; Lucas A; McFadden G; Macaulay C
Clin Immunol; 2014 Aug; 153(2):254-63. PubMed ID: 24845791
[TBL] [Abstract][Full Text] [Related]
6. Serpins, the vasculature, and viral therapeutics.
Richardson J; Viswanathan K; Lucas A
Front Biosci; 2006 Jan; 11():1042-56. PubMed ID: 16146796
[TBL] [Abstract][Full Text] [Related]
7. SERP1, a serine proteinase inhibitor encoded by myxoma virus, is a secreted glycoprotein that interferes with inflammation.
Macen JL; Upton C; Nation N; McFadden G
Virology; 1993 Aug; 195(2):348-63. PubMed ID: 8337817
[TBL] [Abstract][Full Text] [Related]
8. Serpins: Development for Therapeutic Applications.
Lucas A; Yaron JR; Zhang L; Macaulay C; McFadden G
Methods Mol Biol; 2018; 1826():255-265. PubMed ID: 30194606
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of plasmin, urokinase, tissue plasminogen activator, and C1S by a myxoma virus serine proteinase inhibitor.
Lomas DA; Evans DL; Upton C; McFadden G; Carrell RW
J Biol Chem; 1993 Jan; 268(1):516-21. PubMed ID: 8416956
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory specificity of the anti-inflammatory myxoma virus serpin, SERP-1.
Nash P; Whitty A; Handwerker J; Macen J; McFadden G
J Biol Chem; 1998 Aug; 273(33):20982-91. PubMed ID: 9694848
[TBL] [Abstract][Full Text] [Related]
11. The cowpox virus SPI-3 and myxoma virus SERP1 serpins are not functionally interchangeable despite their similar proteinase inhibition profiles in vitro.
Wang YX; Turner PC; Ness TL; Moon KB; Schoeb TR; Moyer RW
Virology; 2000 Jul; 272(2):281-92. PubMed ID: 10873771
[TBL] [Abstract][Full Text] [Related]
12. The role of cell signaling in poxvirus tropism: the case of the M-T5 host range protein of myxoma virus.
Werden SJ; McFadden G
Biochim Biophys Acta; 2008 Jan; 1784(1):228-37. PubMed ID: 17905673
[TBL] [Abstract][Full Text] [Related]
13. Myxoma virus and malignant rabbit fibroma virus encode a serpin-like protein important for virus virulence.
Upton C; Macen JL; Wishart DS; McFadden G
Virology; 1990 Dec; 179(2):618-31. PubMed ID: 2173255
[TBL] [Abstract][Full Text] [Related]
14. SERP-1, a poxvirus-encoded serpin, is expressed as a secreted glycoprotein that inhibits the inflammatory response to myxoma virus infection.
Nash P; Lucas A; McFadden G
Adv Exp Med Biol; 1997; 425():195-205. PubMed ID: 9433502
[No Abstract] [Full Text] [Related]
15. Recent progress in understanding the diversity of the human ov-serpin/clade B serpin family.
Izuhara K; Ohta S; Kanaji S; Shiraishi H; Arima K
Cell Mol Life Sci; 2008 Aug; 65(16):2541-53. PubMed ID: 18516497
[TBL] [Abstract][Full Text] [Related]
16. Metabolism and distribution of the virus-encoded serine proteinase inhibitor SERP-1 in healthy rabbits.
Hatton MW; Ross B; Southward SM; Lucas A
Metabolism; 2000 Nov; 49(11):1449-52. PubMed ID: 11092510
[TBL] [Abstract][Full Text] [Related]
17. Viral serpin therapeutics from concept to clinic.
Chen H; Zheng D; Davids J; Bartee MY; Dai E; Liu L; Petrov L; Macaulay C; Thoburn R; Sobel E; Moyer R; McFadden G; Lucas A
Methods Enzymol; 2011; 499():301-29. PubMed ID: 21683260
[TBL] [Abstract][Full Text] [Related]
18. Crystal Structure of Cleaved Serp-1, a Myxomavirus-Derived Immune Modulating Serpin: Structural Design of Serpin Reactive Center Loop Peptides with Improved Therapeutic Function.
Mahon BP; Ambadapadi S; Yaron JR; Lomelino CL; Pinard MA; Keinan S; Kurnikov I; Macaulay C; Zhang L; Reeves W; McFadden G; Tibbetts S; McKenna R; Lucas AR
Biochemistry; 2018 Feb; 57(7):1096-1107. PubMed ID: 29227673
[TBL] [Abstract][Full Text] [Related]
19. Viral SERPINS-A Family of Highly Potent Immune-Modulating Therapeutic Proteins.
Varkoly K; Beladi R; Hamada M; McFadden G; Irving J; Lucas AR
Biomolecules; 2023 Sep; 13(9):. PubMed ID: 37759793
[TBL] [Abstract][Full Text] [Related]
20. Adeno-Associated Virus Delivery of Viral Serpins for Ocular Diseases: Design and Validation.
Ildefonso CJ; Lewin AS
Methods Mol Biol; 2018; 1826():237-254. PubMed ID: 30194605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
